Thymmune Therapeutics

Thymic engineering platform and cell therapies

Thymmune Therapeutics is focused on restoring immune function through innovative thymic cell engineering. Their platform leverages induced pluripotent stem cells (iPSCs) to generate functional thymic cells and potentially functional thymus tissue, offering a potential solution for patients with impaired immune systems. Thymmune is developing therapies for patients with congenital or acquired immunodeficiencies. Their technology aims to address immune-related complications associated with organ transplantation. Thymmune is exploring the potential of their platform to rejuvenate the immune system in aging individuals. Thymmune Therapeutics is leading the Thymus Rejuvenation Project, which aims to restore non-functional thymus tissue.